| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.13 | 0.3 |